# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000899140-22-000449
Filing Date
2022-04-07
Accepted
2022-04-07 17:09:31
Documents
24
Period of Report
2022-04-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8K | i52073961a.htm | 8-K | 12521
2 | CORPORATE PRESENTATION | i52073961d.htm | EX-99.1 | 50837
3 |  | i52073961dslide1.jpg | GRAPHIC | 93656
4 |  | i52073961dslide2.jpg | GRAPHIC | 80417
5 |  | i52073961dslide3.jpg | GRAPHIC | 298585
6 |  | i52073961dslide4.jpg | GRAPHIC | 142295
7 |  | i52073961dslide5.jpg | GRAPHIC | 112839
8 |  | i52073961dslide6.jpg | GRAPHIC | 141971
9 |  | i52073961dslide7.jpg | GRAPHIC | 171774
10 |  | i52073961dslide8.jpg | GRAPHIC | 147496
11 |  | i52073961dslide9.jpg | GRAPHIC | 131263
12 |  | i52073961dslide10.jpg | GRAPHIC | 226494
13 |  | i52073961dslide12.jpg | GRAPHIC | 198089
14 |  | i52073961dslide13.jpg | GRAPHIC | 148827
15 |  | i52073961dslide14.jpg | GRAPHIC | 98410
16 |  | i52073961dslide15.jpg | GRAPHIC | 26036
17 |  | i52073961dslide16.jpg | GRAPHIC | 167225
18 |  | i52073961dslide17.jpg | GRAPHIC | 163926
19 |  | i52073961dslide18.jpg | GRAPHIC | 176420
20 |  | i52073961dslide19.jpg | GRAPHIC | 119303
21 |  | i52073961dslide20.jpg | GRAPHIC | 175189
22 |  | i52073961dslide21.jpg | GRAPHIC | 209255
23 |  | i52073961dslide22.jpg | GRAPHIC | 163938
24 |  | i52073961dslide33.jpg | GRAPHIC | 197700
| Complete submission text file | 0000899140-22-000449.txt |  | 4737370

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 22814612
SIC: 2834 Pharmaceutical Preparations